Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Symrise AG: A reportable insider transaction was published on 4th August 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 4th August 2025,
The Insider Transaction was made by Ribeiro, Walter 
. The transaction toke place on 31st July 2025. The order was executed at the trading place Tradegate (Best Execution). . The aggregated volume was 32.188,00 EUR, based on an average price of 80,47 EUR. The nature of the Investment was Buy.
Symrise AG: A reportable insider transaction was published on 4th August 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 4th August 2025,
The Insider Transaction was made by Ribeiro, Walter . The transaction toke place on 30th July 2025. The order was executed at the trading place Frankfurt. . The aggregated volume was 32.800,00 EUR, based on an average price of 82,00 EUR. The nature of the Investment was Buy.
Symrise AG: A reportable insider transaction was published on 4th August 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 4th August 2025,
The Insider Transaction was made by Ribeiro, Walter . The transaction toke place on 29th July 2025. The order was executed at the trading place Frankfurt. . The aggregated volume was 25.926,00 EUR, based on an average price of 86,42 EUR. The nature of the Investment was Buy.
Symrise AG: A reportable insider transaction was published on 26th June 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 26th June 2025,
The Insider Transaction was made by Ribeiro, Walter . The transaction toke place on 24th June 2025. The order was executed at the trading place UBS EUROPE SE. . The aggregated volume was 58.200,00 EUR, based on an average price of 97,00 EUR. The nature of the Investment was Buy.
Bayerische Motoren Werke Aktiengesellschaft: A reportable insider transaction was published on 2nd June 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 2nd June 2025,
The Insider Transaction was made by Mertl, Walter . The transaction toke place on 30th May 2025. . The aggregated volume was 174.878,49 EUR, based on an average price of 78,60 EUR. The nature of the Investment was Buy.
DLB - Anlageservice Aktiengesellschaft: A reportable insider transaction was published on 7th April 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 7th April 2025,
The Insider Transaction was made by Pichler, Walter . The transaction toke place on 4th April 2025. The order was executed at the trading place Börse Stuttgart. . The aggregated volume was 9.558,30 EUR, based on an average price of 15,10 EUR. The nature of the Investment was Buy.
Redcare Pharmacy N.V.: A reportable insider transaction was published on 5th February 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 5th February 2025,
The Insider Transaction was made by Köhler, Frank Roland Walter . The transaction toke place on 4th February 2025. The order was executed at the trading place XETRA. . The aggregated volume was 119.500,00 EUR, based on an average price of 119,50 EUR. The nature of the Investment was Buy.
Ringmetall SE: A reportable insider transaction was published on 3rd February 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 3rd February 2025,
The Insider Transaction was made by Wenner, Markus Walter . The transaction toke place on 30th January 2025. The order was executed at the trading place XETRA. . The aggregated volume was 11.137,32 EUR, based on an average price of 3,71 EUR. The nature of the Investment was not specified.
Ringmetall SE: A reportable insider transaction was published on 3rd February 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 3rd February 2025,
The Insider Transaction was made by Wenner, Markus Walter . The transaction toke place on 29th January 2025. The order was executed at the trading place XETRA. . The aggregated volume was 11.130,00 EUR, based on an average price of 3,71 EUR. The nature of the Investment was not specified.
Ringmetall SE: A reportable insider transaction was published on 3rd February 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 3rd February 2025,
The Insider Transaction was made by Wenner, Markus Walter . The transaction toke place on 31st January 2025. The order was executed at the trading place XETRA. . The aggregated volume was 7.320,00 EUR, based on an average price of 3,66 EUR. The nature of the Investment was not specified.
Heidelberg Pharma AG: A reportable insider transaction was published on 29th August 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 29th August 2024,
The Insider Transaction was made by Miller, Walter . The transaction toke place on 28th August 2024. The order was executed at the trading place Xetra. . The aggregated volume was 4.985,50 EUR, based on an average price of 2,49 EUR. The nature of the Investment was Buy.
Heidelberg Pharma AG: A reportable insider transaction was published on 29th August 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 29th August 2024,
The Insider Transaction was made by Miller, Walter . The transaction toke place on 28th August 2024. The order was executed at the trading place Berlin Tradegate. . The aggregated volume was 4.968,08 EUR, based on an average price of 2,48 EUR. The nature of the Investment was Buy.
Bayerische Motoren Werke Aktiengesellschaft: A reportable insider transaction was published on 3rd June 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 3rd June 2024,
The Insider Transaction was made by Mertl, Walter . The transaction toke place on 31st May 2024. . The aggregated volume was 464.929,99 EUR, based on an average price of 92,74 EUR. The nature of the Investment was Buy.
Bayerische Motoren Werke Aktiengesellschaft: A reportable insider transaction was published on 27th May 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 27th May 2024,
The Insider Transaction was made by Mertl, Walter . The transaction toke place on 27th May 2024. . The aggregated volume was 26.746,70 EUR, based on an average price of 93,19 EUR. The nature of the Investment was Buy.
Heidelberg Pharma AG: A reportable insider transaction was published on 17th April 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 17th April 2024,
The Insider Transaction was made by Miller, Walter . The transaction toke place on 15th April 2024. The order was executed at the trading place Berlin Tradegate. . The aggregated volume was 6.050,00 EUR, based on an average price of 3,02 EUR. The nature of the Investment was Buy.
Bayerische Motoren Werke Aktiengesellschaft: A reportable insider transaction was published on 31st May 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 31st May 2023,
The Insider Transaction was made by Mertl, Walter . The transaction toke place on 30th May 2023. . The aggregated volume was 51.806,63 EUR, based on an average price of 105,08 EUR. The nature of the Investment was Buy.
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.